Bedke J, Arkosy P, Nishiyama H, Mahammedi H, et al. Perioperative pembrolizumab or placebo plus neoadjuvant cisplatin and gemcitabine in participants with muscle-invasive bladder cancer who are eligible for cisplatin: the double-blind, phase III KEYNOTE-866 study. Ann Oncol 2026 Oct 23:S0923-7534(26)06888-2. doi: 10.1016/j.annonc.2026.
PMID: 42918422